Skip to content

Public FDA record

Z-0830-2025: Impella RP Flex with SmartAssist; Product Number: 1000323;

Recall record Z-0830-2025 for Abiomed, Inc.. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-0830-2025
Company in FDA record
Abiomed, Inc.
FDA classification date
Jan 15, 2025
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 16, 2026
Recall classification
Class I

Reason stated in the source

Optical Sensors have been damaged due to physical interaction between the inlet and another device resulting in a Placement Signal Not Reliable (PSNR) alarm and loss of Central Venous (CV) Placement Signal, Pulmonary Artery (PA) Placement Signal & Pulmonary Artery Pulse Index (PAPi) metrics. Abiomed is reinforcing that there is a risk of potential interaction between the tip of guidewires, indwelling central venous lines or devices and inlet of the Impella pumps listed above during the insertion, manipulation, and removal of those devices. The interaction may result in optical sensor damage, temporary pump stop, or permanent pump stop.

Source facts

Action
On December 13, 2024, URGENT MEDICAL DEVICE CORRECTION (NOTIFICATION) letters were sent to customers. RECOMMENDATIONS: Product is not being removed and hospital inventory may continue to be used. It is recommended that users lower the pump flow level to P-2 and use imaging guidance when inserting, manipulating, or removing any guidewires, indwelling venous lines or devices to reduce the potential for interaction of the device tip with the pump inlet. If optical sensor damage occurs and Placement Signal Not Reliable (PSNR) alarm is displayed no additional actions are required. Hemodynamic support and Impella position are not affected and can be monitored as part of routine patient/pump management. In addition, calculated flow and suction monitoring are also unaffected when an optical sensor PSNR alarm is displayed. In the event of a pump stop, follow the displayed prompts of the Impella Stopped alarm. Damage to the guidewire, indwelling central venous line or other device involved in the unintended interaction should be evaluated, and users should assess if a new device is required. ACTIONS TO BE TAKEN BY CUSTOMER/USER: - Product is NOT being removed from the field and does not need to be returned. - Review, complete all fields, sign, and return the attached business response form (BRF) (refer to Attachment 2) to Abiomed6329@sedgwick.com. - Forward this notice to anyone in your facility that needs to be informed (i.e., those who manage, transport, store, stock, or use the subject products). - If any of the subject products have been forwarded to another facility, contact that facility and provide them with this notice. - Post a copy of this notice in a visible area for awareness. As with any medical device, adverse reactions or quality problems experienced with the use of this product should be reported to the FDA s MedWatch Adverse Event Reporting Program as per below instructions: - Complete and submit the report online: www.fda.gov/medwatch/report.htm or Regula
Initiated
2024-12-12
Root cause
Under Investigation by firm
Distribution
Domestic: Nationwide Distribution International: Canada
Recall number
Z-0830-2025
Recall status
Open, Classified
CDRH record ID
211200
FDA classified
2025-01-15
Recall event number
95780

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗